7 recruiting, 4 completed, 2 active not recruiting, 2 unknown. 2 Not applicable, 2 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Active not recruiting 1, Completed 1 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Coronary Artery Disease Progression: new trials by email Literature Review of Coronary Artery Disease Progression trials Research Report on Coronary Artery Disease Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis Rosuvastatin 20 Mg Oral Tablet, Colchicine 0.5 MG Oral Tablet Once Daily, Placebo - Coronary Artery Disease Risk Factors Multiple, Coronary Artery Disease Progression | Phase 3 | Recruiting | Duke University | 1500 | 2026-07-21 | 2026-10-07 |
| Disease Characteristics of R-CAD Protocol-defined Examinations and Evaluations - Coronary Artery Disease, Coronary Artery Disease Progression | Not yet recruiting | Peking Union Medical College Hospital | 52 | 2025-11-01 | 2025-11-28 | |
| Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study Healthy life style, Secondary prevention for atherosclerotic coronary artery disease, Immunosuppressive Therapy - Coronary Artery Disease, Coronary Artery Disease Progression | Recruiting | Peking Union Medical College Hospital | 120 | 2025-04-01 | 2025-11-19 | |
| Natural History of Coronary Atherosclerosis Coronary Artery Disease Progression, Radial Wall Strain | Recruiting | China National Center for Cardiovascular Diseases | 125 | 2024-07-07 | 2024-11-06 | |
| Disease Characteristics of IR-CAD: a Case-control Study Protocol-defined Examinations - Coronary Artery Disease, Coronary Artery Stenosis | Recruiting | Peking Union Medical College Hospital | 30 | 2023-11-02 | 2025-11-19 | |
| Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study Healthy life style, Secondary prevention for atherosclerotic coronary artery disease, Immunosuppressive therapy - Coronary Artery Disease, Coronary Artery Stenosis | Recruiting | Peking Union Medical College Hospital | 39 | 2023-05-17 | 2025-11-19 | |
| Proteomics and Genomics Combined With CT to Predict CVD Coronary Artery Disease Progression | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 312 | 2023-01-12 | 2026-10-29 | |
| Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population Intensive lipid-lowering control, Moderate-intensity lipid-lowering control - Coronary Artery Disease Progression | Not applicable | Active not recruiting | Chinese Academy of Medical Sciences, Fuwai Hospital | 2900 | 2022-10-10 | 2026-07-20 |
| Plaque Reversal With Early, Aggressive Lipid Lowering Therapy Coronary Artery Disease Progression | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 60 | 2022-07-07 | 2025-10-02 | |
| Prior CABG Patients Evaluated for Saphenous VeIn grAft DysfUnction and Progression of Coronary arTery Disease Recurrent Angina After Coronary Artery Bypass Graft, Graft Failure | Recruiting | Amsterdam UMC, location VUmc | 500 | 2019-08-23 | 2023-06-02 | |
| Sirtuin-1 and Advanced Glycation End-products in Postmenopausal Women With Coronary Disease Quercetin - Coronary Artery Disease Progression | Phase 3 | Unknown | InCor Heart Institute | 60 | 2019-08-02 | 2019-10-04 |
| Evaluation of Effectiveness and Safety of Hybrid Coronary Revascularization Hybrid Coronary Revascularization - Percutaneous Coronary Revascularization, Coronary Stenosis | Terminated | Seung-Jung Park | 6 | 2019-04-05 | 2026-04-15 | |
| To Evaluate the Efficacy of Alirocumab for Neoatherosclerosis by Using OCT, in Comparison With Standard Statin Therapy Alirocumab - Coronary Artery Disease Progression | Unknown | Kobe University | 31 | 2017-12-18 | 2018-05-30 | |
| Registry of Secondary Revascularization Coronary Artery Disease Progression, Coronary Artery Disease of Significant Bypass Graft | Active not recruiting | Hospital San Carlos, Madrid | 869 | 2017-11-22 | 2025-04-24 | |
| Critical Treatment of Coronary Artery Disease Stent implantation - Coronary Artery Disease, Coronary Artery Disease Progression | Not applicable | Completed | Southeast University, China | 200 | 2016-07-01 | 2023-04-14 |
| Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial EPA and high dose rosuvastatin, Standard dose rosuvastatin - Coronary Artery Disease Progression | Phase 4 | Completed | Kobe University | 50 | 2013-07-26 | 2018-01-09 |
| Relation Among HDL Functionality, Neoatherosclerosis and Target Lesion Revascularization neoatherosclerosis - Coronary Artery Disease Progression | Completed | Kobe University | 181 | 2011-05-01 | 2018-05-30 |
Coronary Artery Disease (7) · Coronary Stenosis (5) · Coronary Restenosis (4) · Disease Progression (4) · Inflammation (3) · Angina Pectoris (1) · Disease Attributes (1)
Cardiovascular Diseases (9) · Heart Diseases (9) · Myocardial Ischemia (9) · Vascular Diseases (9) · Coronary Disease (8) · Arterial Occlusive Diseases (7) · Arteriosclerosis (7) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Disease Attributes (3) · Chest Pain (1) · Neurologic Manifestations (1) · Pain (1) · Signs and Symptoms (1)
Immunosuppression Therapy (2) · Percutaneous Coronary Intervention (2) · Rosuvastatin Calcium (2) · Secondary Prevention (2) · Atorvastatin (1) · Colchicine (1) · Eicosapentaenoic Acid (1) · Physical Examination (1) · Quercetin (1) · Tablets (1) · alirocumab (1)
Peking Union Medical College Hospital (4) · Kobe University (3) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · Amsterdam UMC, location VUmc (1) · China National Center for Cardiovascular Diseases (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · Duke University (1) · Hospital San Carlos, Madrid (1) · InCor Heart Institute (1) · Seung-Jung Park (1) · Southeast University, China (1)
China (6) · Netherlands (3) · Japan (2) · Brazil (1) · South Korea (1) · Spain (1) · United States (1)
Zhenyu Liu, M.D. (3) · Antonio P Mansur, PhD (1) · Erik SG Stroes, MD PhD (1) · Erik SG Stroes, MD, PhD (1) · Gen-shan Ma, Ph.D (1) · Hiromasa Otake, M.D., Ph.D (1) · Hiromasa Otake, PhD (1) · Hiromasa Otake, ph.D (1) · Lei Song, MD (1) · Pablo Salinas, MD, PhD (1) · Paul Knaapen, Professor (1)
PMID 37277217, PMID 37582340, PMID 39991799, PMID 41130689
UG3HL181434 (1)